IDRx Revenue and Competitors
Estimated Revenue & Valuation
- IDRx's estimated annual revenue is currently $2.6M per year.
- IDRx's estimated revenue per employee is $77,500
- IDRx's total funding is $122M.
Employee Data
- IDRx has 33 Employees.
- IDRx grew their employee count by 43% last year.
IDRx's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO, Founder | Reveal Email/Phone |
2 | Co-Founder and CEO | Reveal Email/Phone |
3 | Co-Founder | Reveal Email/Phone |
4 | Co-Founder | Reveal Email/Phone |
5 | Co-Founder | Reveal Email/Phone |
6 | Co-Founder | Reveal Email/Phone |
7 | Chief Product Development Officer | Reveal Email/Phone |
8 | Chief Development Operations Officer | Reveal Email/Phone |
9 | VP, DMPK, M&S and Clinical Pharmacology | Reveal Email/Phone |
10 | VP, Pharmaceutical Sciences | Reveal Email/Phone |
IDRx Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is IDRx?
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies. Inspired by a few curative combination regimens in cancer and the successful drug cocktails purposely engineered in other disease areas such as cystic fibrosis and antivirals, IDRx aims to address the limitations of today’s precision cancer medicines with highly -selective, purposely -designed drug combinations to help more patients achieve prolonged, durable responses to therapy earlier in the course of their disease. Founded in 2022, IDRx’s leadership team has extensive experience in drug development, and collectively has been involved in the discovery, development and commercialization of more than 10 approved drugs.
keywords:N/A
$122M
Total Funding
33
Number of Employees
$2.6M
Revenue (est)
43%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6M | 33 | -43% | N/A |
#2 | $7.5M | 33 | 3% | N/A |
#3 | $4.8M | 33 | 32% | N/A |
#4 | $4.2M | 33 | 6% | N/A |
#5 | $6.7M | 33 | 0% | N/A |